chevron_leftBack
As of 20 June 2026, Mycenax Biotech Inc. has a market cap of $191.69M USD, ranking #21340 globally and #983 in Taiwan.
It ranks #1903 in the Healthcare sector, and #369 in the Biotechnology industry.
Key Stats
Market Cap
$191.69MUSD
6.06B TWD
Enterprise Value
$218.36MUSD
6.91B TWD
Revenue (TTM)
$23.41MUSD
740.24M TWD
EBITDA (TTM)
-$5.33MUSD
-168.6M TWD
Net Income (TTM)
-$14.19MUSD
-448.63M TWD
EBITDA Margin
-23%
Profit Margin
-61%
PS Ratio
8.2
PB Ratio
3.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Pei-Jiun Chen
open_in_new
Employees
387
Founded
2001
Website
mycenax.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -0.7% | -8.6% | -16% | -14% | -12% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4726
永昕生物醫藥股份有限公司
ISIN: TW0004726005
Shares Out.:
Shares Outstanding:
207.042M1
Shares Float:
172.022M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
29.25 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Mycenax Biotech Inc.
Mycenax Biotech Inc. provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company’s services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers plasmid DNA, antibody-drug conjugates, cell and gene therapy, and exosomes products and services. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
3K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
740%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
462%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
279%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
213%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
198%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
95K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
83K%
|
19.0
|
|
EBR: ARGX
|
$47.43B
25K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
23K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
22K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
22K%
33.71B CHF
|
37.2
|
chevron_leftBack